Therefore, interventions that inhibit NETosis, S100A8/A9, and IL‐1β during the acute inflammatory phase after myocardial infarction may exert beneficial effects on the post‐infarction inflammatory process and ventricular remodelling.15 This evidence concerns the gene S100A8 and myocardial infarction.